
|Articles|February 1, 2004
- LCGC North America-02-01-2004
- Volume 22
- Issue 2
Investigating Out-of-Specification Results
This column discusses potential sources and ways to avoid out-of-specification (OOS) results and highlights the draft FDA guidelines on OOS investigations.
Advertisement
Articles in this issue
over 22 years ago
From the Editorover 22 years ago
Pittcon Product Showcaseover 22 years ago
Peaks of Interestover 22 years ago
Debating Resolution and Mass Accuracyover 22 years ago
Selecting the Best Curve Fitover 22 years ago
Developments in 2-D Gas Chromatography with Heartcuttingover 22 years ago
CalendarAdvertisement
Advertisement
Advertisement




